Alvotech(ALVO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALVO Alvotech

交易中 06-10 10:49:31 EDT

4.12

-0.04

-1.08%

最高4.19	最低4.05	成交量15.38万
今开4.09	昨收4.16	日振幅3.25%
总市值12.88亿	流通市值4.78亿	总股本3.13亿
成交额63.53万	换手率0.13%	流通股本1.16亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALVO","market":"US","secType":"STK","nameCN":"Alvotech","latestPrice":4.115,"timestamp":1781102960201,"preClose":4.16,"halted":0,"volume":153766,"delay":0,"changeRate":-0.010817307692307675,"floatShares":116174008,"shares":313000000,"eps":0.0964,"marketStatus":"交易中","change":-0.045,"latestTime":"06-10 10:49:31 EDT","open":4.09,"high":4.185,"low":4.05,"amount":635320.517776,"amplitude":0.032452,"askPrice":4.12,"askSize":268,"bidPrice":4.11,"bidSize":400,"shortable":3,"etf":0,"ttmEps":0.0964,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1781121600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":4.16,"preHourTrading":{"tag":"盘前","latestPrice":4.1,"preClose":4.16,"latestTime":"09:25 EDT","volume":1588,"amount":6622.9694916,"timestamp":1781097913270,"change":-0.06,"changeRate":-0.014423,"amplitude":0.026442},"postHourTrading":{"tag":"盘后","latestPrice":4.12,"preClose":4.16,"latestTime":"19:55 EDT","volume":6628,"amount":27545.12,"timestamp":1781049331794,"change":-0.04,"changeRate":-0.009615,"amplitude":0.010817},"volumeRatio":0.575585},"requestUrl":"/m/hq/s/ALVO/wiki","defaultTab":"wiki","newsList":[{"id":"1146000160","title":"Alvotech宣布FDA受理其拟议可互换生物类似药Avt16的生物制品许可申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1146000160","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146000160?lang=zh_cn&edition=full","pubTime":"2026-06-08 16:01","pubTimestamp":1780905690,"startTime":"0","endTime":"0","summary":"Alvotech公司宣布，美国食品药品监督管理局（FDA）已正式受理其生物制品许可申请（BLA），该申请针对的是其拟议产品Avt16。Avt16是一种旨在与Entyvio®进行互换的生物类似药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641164638","title":"Alvotech再次向FDA提交强生Simponi和再生元Eylea生物类似药上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2641164638","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641164638?lang=zh_cn&edition=full","pubTime":"2026-06-05 03:16","pubTimestamp":1780600560,"startTime":"0","endTime":"0","summary":"冰岛生物制药公司Alvotech周四宣布，已再次向美国食品药品监督管理局提交两款生物类似药的生物制剂许可申请，分别针对强生的Simponi和再生元的Eylea。此次提交是与合作伙伴Teva共同推进的，标志着两家公司在拓展美国生物类似药市场方面迈出关键一步。AVT05是强生旗下Simponi及其静脉注射剂型Simponi Aria的生物类似药，该药属于肿瘤坏死因子阻滞剂，用于治疗类风湿关节炎、银屑病关节炎、强直性脊柱炎、溃疡性结肠炎等多种慢性炎症性疾病。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-05/doc-iniahtfh8923892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0053666078.USD","LU2430703178.SGD","IE00BDGV0183.EUR","LU1066051225.USD","LU1228905037.USD","IE00BLSP4239.USD","ALVO","LU2133065610.SGD","LU0545562505.USD","SG9999002232.USD","IE00B1BXHZ80.USD","LU1032466523.USD","LU1551013425.SGD","LU0203345920.USD","IE000F7OJYX1.SGD","IE00BLSP4452.SGD","LU1121112475.USD","IE00B19Z3581.USD","BK4504","LU1280957306.USD","BK4139","LU1894683348.USD","IE00B3PB1722.GBP","LU2750360641.GBP","IE00BN8TJ469.HKD","LU0683600562.USD","LU1074936037.SGD","SG9999001176.USD","LU0882574055.USD","LU0432979614.USD","LU1244550577.SGD","LU1585245621.USD","LU2112291526.USD","BK4592","LABU","LU0964807845.USD","LU1629891620.HKD","IE000BZT7R73.USD","LU2417539215.USD","LU0689626769.HKD","IE00B3T34201.USD","IE00BJT1NW94.SGD","BK4588","IPOS","LU1261432733.SGD","LU2213496289.HKD","JNJ","BK4007","IE000SO60NU8.SGD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138345689","title":"Alvotech宣布重新提交Avt05与Avt06在美生物制品许可申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1138345689","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138345689?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:01","pubTimestamp":1780560079,"startTime":"0","endTime":"0","summary":"Alvotech公司宣布，已重新向美国食品药品监督管理局提交了其生物类似药产品Avt05与Avt06的生物制品许可申请。\nAvt05是参照原研药Simponi®及Simponi Aria®开发的生物类似药候选产品。而Avt06则是参照原研药Eylea®开发的生物类似药候选产品。\n此次重新提交申请，标志着该公司在推动这些重要生物类似药于美国市场上市的过程中迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157608217","title":"Alvotech与Islandsbanki续签做市协议 其股票将继续在纳斯达克冰岛交易所交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1157608217","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157608217?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:32","pubTimestamp":1780302736,"startTime":"0","endTime":"0","summary":"Alvotech与Islandsbanki已就续签做市协议达成一致，该协议旨在为Alvotech股票在纳斯达克冰岛交易所的交易提供流动性支持。此举意味着，在Islandsbanki的持续做市服务下，Alvo股票的二级市场交易将获得更稳定的报价与更顺畅的交易体验。协议的续签反映了双方对维持该股票市场活跃度与效率的共同承诺，也旨在为投资者营造一个更具深度且可靠的交易环境。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162703760","title":"财报前瞻｜Alvotech本季度营收预计增48.23%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1162703760","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162703760?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:30","pubTimestamp":1777455012,"startTime":"0","endTime":"0","summary":"Alvotech将于2026年05月06日发布2026年第一季度财报，市场聚焦产品放量与费用结构变化对盈利的影响。市场一致预期本季度Alvotech营收约为1.41亿美元，同比增48.23%；调整后每股收益预计为0.02美元，同比增115.16%；息税前利润预计为3,233.67万美元，同比增361.31%。上一季度Alvotech实现营收1.69亿美元，同比增长10.14%；毛利率为63.72%；归属于母公司股东的净亏损为-1.09亿美元，净利率为-64.27%；调整后每股收益为-0.37美元，同比下降54.17%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Alvotech本季度营收预计增48.23%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153071007","title":"财报前瞻｜Alvotech本季度营收预计增长43.01%，机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1153071007","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153071007?lang=zh_cn&edition=full","pubTime":"2026-03-11 10:52","pubTimestamp":1773197579,"startTime":"0","endTime":"0","summary":"Alvotech将于2026年03月18日发布最新季度财报，市场关注营收放量与盈利改善的节奏，以及核心管线放量对利润率的拉动。市场一致预期显示，Alvotech本季度营收预计为1.65亿美元，同比增长43.01%；预计调整后每股收益为-0.05美元，同比改善88.33%；预计息税前利润为3,833.00万美元，同比增长61.60%。近六个月路演与卖方研判对Alvotech的态度偏正面，看多观点占比较高。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Alvotech本季度营收预计增长43.01%，机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618673984","title":"Alvotech盘中异动 早盘股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618673984","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618673984?lang=zh_cn&edition=full","pubTime":"2026-03-09 22:12","pubTimestamp":1773065548,"startTime":"0","endTime":"0","summary":"北京时间2026年03月09日22时12分，Alvotech股票出现波动，股价快速下挫5.24%。截至发稿，该股报3.80美元/股，成交量5.8441万股，换手率0.02%，振幅3.49%。Alvotech股票所在的制药行业中，整体跌幅为0.90%。其相关个股中，Hims & Hers Health, Inc.、Biofrontera Inc C/Wts 27/10/2026 、Medicus Pharma Ltd.涨幅较大，Hims & Hers Health, Inc.、Medicus Pharma Ltd.、Inmed Pharmaceuticals Inc.较为活跃，换手率分别为27.68%、13.15%、3.12%，振幅较大的相关个股有Biofrontera Inc C/Wts 27/10/2026 、Medicus Pharma Ltd.、Hims & Hers Health, Inc.，振幅分别为29.57%、16.63%、16.14%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309221228a45beafa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309221228a45beafa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616360345","title":"Alvotech盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616360345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616360345?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:59","pubTimestamp":1772463559,"startTime":"0","endTime":"0","summary":"北京时间2026年03月02日22时59分，Alvotech股票出现异动，股价急速跳水5.01%。截至发稿，该股报3.79美元/股，成交量14.1675万股，换手率0.05%，振幅3.62%。Alvotech股票所在的制药行业中，整体跌幅为0.08%。其相关个股中，Eton Pharmaceuticals, Inc.、Hims & Hers Health, Inc.、Im Cannabis Corp.涨幅较大，Hims & Hers Health, Inc.、Incannex Healthcare Inc.、Akanda Corp.较为活跃，换手率分别为2.16%、2.06%、1.72%，振幅较大的相关个股有Sunshine Biopharma Inc C/Wts 、Inmed Pharmaceuticals Inc.、Incannex Healthcare Inc.，振幅分别为17.11%、11.11%、9.91%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302225919a442a143&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302225919a442a143&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114971853","title":"Alvotech公布其恩利优®（Entyvio®）拟议生物类似药关键药代动力学研究的积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1114971853","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114971853?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:00","pubTimestamp":1770278415,"startTime":"0","endTime":"0","summary":"生物制药公司Alvotech近日宣布，其针对参考药物恩利优®（Entyvio®）开发的拟议生物类似药，在一项关键性药代动力学研究中取得了积极的顶线结果。该研究旨在评估候选生物类似药与参照药在健康受试者体内的药代动力学相似性。初步数据显示，研究达到了其主要终点，证明了两者在关键药代动力学参数上具有生物等效性。这一积极进展标志着Alvotech在该生物类似药的研发道路上迈出了重要一步，为其后续向监管机构提交上市申请奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608335857","title":"Alvotech盘中异动 下午盘快速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608335857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608335857?lang=zh_cn&edition=full","pubTime":"2026-02-04 03:03","pubTimestamp":1770145425,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日03时03分，Alvotech股票出现波动，股价急速下跌5.08%。截至发稿，该股报5.05美元/股，成交量15.47万股，换手率0.05%，振幅7.24%。Alvotech股票所在的制药行业中，整体跌幅为1.85%。其相关个股中，Biofrontera Inc C/Wts 27/10/2026 、Caring Brands, Inc.、Evotec Se涨幅较大，苏轩堂、惠普森医药、大自然药业较为活跃，换手率分别为34.80%、20.22%、10.25%，振幅较大的相关个股有惠普森医药、苏轩堂、Caring Brands, Inc.，振幅分别为53.88%、30.51%、18.69%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204030346a478908b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204030346a478908b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173259963","title":"Alvotech与加拿大及澳新地区达成多项生物类似药候选产品的供应与商业化协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1173259963","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173259963?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:08","pubTimestamp":1770019712,"startTime":"0","endTime":"0","summary":"生物制药公司Alvotech宣布，已与加拿大以及澳大利亚和新西兰地区的合作伙伴签署了多项供应与商业化协议。这些协议涵盖公司管线中多款生物类似药候选产品，旨在将这些高性价比的疗法引入相关市场。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184786153","title":"医保药品价格谈判第三轮选定药物公布：安诺罗易利达、必克特维、保妥适、保妥适美容针、辛齐亚、科森提斯入选","url":"https://stock-news.laohu8.com/highlight/detail?id=1184786153","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184786153?lang=zh_cn&edition=full","pubTime":"2026-01-28 05:40","pubTimestamp":1769550053,"startTime":"0","endTime":"0","summary":"美国医疗保险和医疗补助服务中心近日公布了第三轮药品价格谈判的选定药物名单。此次入围的药品包括用于慢性阻塞性肺病的安诺罗易利达、治疗艾滋病的必克特维、以及广泛应用于医疗与美容领域的保妥适和保妥适美容针。此外，自身免疫疾病治疗药物辛齐亚与科森提斯也成功入选。下一步，CMS将与企业就药品价格进行直接协商，最终谈判价格将于2024年公布。此举被视为美国控制医疗成本上涨的关键措施之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","LU0289739699.SGD","LU2089984988.USD","SG9999015952.SGD","BK4139","LU0889565916.HKD","LU1571399168.USD","LU1066053197.SGD","LU1674673428.USD","LU1430594728.SGD","IE0002270589.USD","LU1839511570.USD","LU1585245621.USD","IE00B19Z3581.USD","SG9999015978.USD","BK4588","LU2324357040.USD","LU0114720955.EUR","LU2468319806.SGD","IE00B19Z3B42.SGD","BK4566","LU0320765992.SGD","IE00BSNM7G36.USD","BK4532","IE00BZ1G4Q59.USD","BK4578","BK4585","IE00B7SZLL34.SGD","LU1778281490.HKD","LU2087621335.USD","BK4583","LU0882574055.USD","SG9999015986.USD","IE00B3T34201.USD","BK4550","ALVO","LU0823416689.USD","SG9999015945.SGD","LU0234570918.USD","BK4568","LU1066051498.USD","LU0058720904.USD","LU0109394709.USD","GILD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600921084","title":"Alvotech C/Wts (To Pur Com)股价拉升12.22% 市值涨452.75万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600921084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600921084?lang=zh_cn&edition=full","pubTime":"2026-01-01 01:47","pubTimestamp":1767203221,"startTime":"0","endTime":"0","summary":"北京时间2026年01月01日01时47分，Alvotech C/Wts 股票出现波动，股价急速上涨12.22%。Alvotech C/Wts 股票所在的制药行业中，整体涨幅为0.14%。其相关个股中，苏轩堂、Alvotech C/Wts 、Alvotech涨幅较大，Akanda Corp.、Cbdmd, Inc.、Inmed Pharmaceuticals Inc.较为活跃，换手率分别为24.82%、8.66%、5.65%，振幅较大的相关个股有Scilex Holding Company C/Wts 10/11/2027 、苏轩堂、Redhill Biopharma Ltd，振幅分别为43.16%、17.02%、12.14%。Alvotech C/Wts 公司简介：Alvotech是一家综合性生物制药公司，致力于为全球患者开发和生产高质量的生物仿制药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260101014701a6e66b2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260101014701a6e66b2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALVO","ALVOW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165154234","title":"Alvotech宣布与合作伙伴Advanz Pharma共同在欧洲推出首款市场上首个生物仿制药Simponi®（Golimumab）","url":"https://stock-news.laohu8.com/highlight/detail?id=1165154234","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165154234?lang=zh_cn&edition=full","pubTime":"2025-12-22 15:08","pubTimestamp":1766387313,"startTime":"0","endTime":"0","summary":"Alvotech宣布与合作伙伴Advanz Pharma共同在欧洲推出市场上首款生物仿制药Simponi®（Golimumab）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102537826","title":"Alvotech与美国商业合作伙伴达成与Regeneron Pharmaceuticals的和解及许可协议，计划在美国推出Avt06","url":"https://stock-news.laohu8.com/highlight/detail?id=1102537826","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102537826?lang=zh_cn&edition=full","pubTime":"2025-12-17 21:47","pubTimestamp":1765979233,"startTime":"0","endTime":"0","summary":"Alvotech与美国商业合作伙伴达成了与Regeneron Pharmaceuticals的和解和许可协议，计划在美国推出Avt06。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151005021","title":"Alvotech Sa - 2026年指引考虑了获得美国FDA某些市场批准的进一步延迟影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1151005021","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151005021?lang=zh_cn&edition=full","pubTime":"2025-12-17 21:43","pubTimestamp":1765979019,"startTime":"0","endTime":"0","summary":"Alvotech Sa - 2026年指引考虑了获得美国FDA某些市场批准的进一步延迟影响","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518200082","title":"Alvotech C/Wts (To Pur Com)盘中异动 股价大跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518200082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518200082?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:45","pubTimestamp":1741614350,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时45分，Alvotech C/Wts 股票出现异动，股价大幅下跌5.53%。Alvotech C/Wts 股票所在的制药行业中，整体跌幅为0.71%。其相关个股中，Sonoma Pharmaceuticals, Inc.、Sunshine Biopharma Inc C/Wts 、大自然药业涨幅较大，Sonoma Pharmaceuticals, Inc.、Petros Pharmaceuticals, Inc.、苏轩堂较为活跃，换手率分别为209.63%、11.50%、4.30%，振幅较大的相关个股有Scilex Holding Company C/Wts 10/11/2027 、Sonoma Pharmaceuticals, Inc.、Alpha Teknova, Inc.，振幅分别为35.91%、30.15%、15.64%。Alvotech C/Wts 公司简介：Alvotech 是一家综合性生物制药公司，致力于为全球患者开发和制造高质量的生物仿制药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214551a26a2a4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214551a26a2a4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALVOW","ALVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517193759","title":"Alvotech盘中异动 股价大跌5.18%报10.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517193759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517193759?lang=zh_cn&edition=full","pubTime":"2025-03-07 01:40","pubTimestamp":1741282856,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日01时40分，Alvotech股票出现异动，股价大幅下跌5.18%。截至发稿，该股报10.71美元/股，成交量5.2143万股，换手率0.02%，振幅2.79%。Alvotech股票所在的制药行业中，整体跌幅为1.57%。其相关个股中，博美集团、Cyclo Therapeutics, Inc.、惠普森医药涨幅较大，Petros Pharmaceuticals, Inc.、苏轩堂、德纳维制药较为活跃，换手率分别为17.24%、9.27%、8.41%，振幅较大的相关个股有Scilex Holding Company C/Wts 10/11/2027 、Cyclo Therapeutics Inc C/Wts 11/12/2025、Medicus Pharma Ltd.，振幅分别为33.03%、26.67%、21.58%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307014056963c6f04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307014056963c6f04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517928839","title":"Alvotech盘中异动 股价大涨5.04%报11.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517928839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517928839?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:10","pubTimestamp":1741198244,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时10分，Alvotech股票出现波动，股价快速上涨5.04%。截至发稿，该股报11.36美元/股，成交量5.5764万股，换手率0.02%，振幅3.33%。Alvotech股票所在的制药行业中，整体涨幅为0.42%。其相关个股中，Sunshine Biopharma Inc C/Wts 、Organogenesis Holdings Inc.、坎伯兰药业涨幅较大，Painreform Ltd.、Petros Pharmaceuticals, Inc.、Cbdmd, Inc.较为活跃，换手率分别为22.96%、12.10%、8.42%，振幅较大的相关个股有坎伯兰药业、Alpha Teknova, Inc.、Organogenesis Holdings Inc.，振幅分别为27.93%、16.89%、15.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306021044989d7632&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306021044989d7632&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517438489","title":"Alvotech C/Wts (To Pur Com)盘中异动 急速拉升10.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517438489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517438489?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:00","pubTimestamp":1741186800,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时00分，Alvotech C/Wts 股票出现波动，股价急速上涨10.24%。Alvotech C/Wts 股票所在的制药行业中，整体涨幅为0.51%。其相关个股中，Medicus Pharma Ltd.、Organogenesis Holdings Inc.、Sunshine Biopharma Inc.涨幅较大，Petros Pharmaceuticals, Inc.、Inmed Pharmaceuticals Inc.、大自然药业较为活跃，换手率分别为4.72%、2.06%、1.02%，振幅较大的相关个股有Alpha Teknova, Inc.、Medicus Pharma Ltd.、Inmed Pharmaceuticals Inc.，振幅分别为16.72%、14.66%、11.61%。Alvotech C/Wts 公司简介：Alvotech 是一家综合性生物制药公司，致力于为全球患者开发和制造高质量的生物仿制药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305230000989d4c53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305230000989d4c53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALVOW","ALVO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alvotech.com","stockEarnings":[{"period":"1week","weight":0.3867},{"period":"1month","weight":0.2761},{"period":"3month","weight":0.1153},{"period":"6month","weight":-0.2765},{"period":"1year","weight":-0.6087},{"period":"ytd","weight":-0.1891}],"compareEarnings":[{"period":"1week","weight":-0.0296},{"period":"1month","weight":-0.0008},{"period":"3month","weight":0.0898},{"period":"6month","weight":0.0695},{"period":"1year","weight":0.2291},{"period":"ytd","weight":0.0808}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Alvotech于2021年8月23日根据卢森堡大公国法律注册成立。该公司是一家生物技术公司，由Robert Wessman创立，专注于为全球患者开发和制造生物仿制药。该公司通过提供高质量、具有成本效益的产品和服务，通过完全集成的方法和广泛的内部能力来寻求成为生物仿制药领域的全球领导者。该公司目前的产品线包含八种生物仿制药候选药物，旨在治疗自身免疫性疾病、眼部疾病、骨质疏松症、呼吸系统疾病和癌症。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.097473},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.03925},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.102535},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.043688},{"month":5,"riseRate":0.5,"avgChangeRate":0.044095},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.055819},{"month":7,"riseRate":0.2,"avgChangeRate":0.0368},{"month":8,"riseRate":0.4,"avgChangeRate":0.00626},{"month":9,"riseRate":0.4,"avgChangeRate":-0.059202},{"month":10,"riseRate":0.4,"avgChangeRate":-0.014607},{"month":11,"riseRate":0.6,"avgChangeRate":-0.068468},{"month":12,"riseRate":0.833333,"avgChangeRate":0.164022}],"exchange":"NASDAQ","name":"Alvotech","nameEN":"Alvotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alvotech(ALVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Alvotech(ALVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Alvotech,ALVO,Alvotech股票,Alvotech股票老虎,Alvotech股票老虎国际,Alvotech行情,Alvotech股票行情,Alvotech股价,Alvotech股市,Alvotech股票价格,Alvotech股票交易,Alvotech股票购买,Alvotech股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alvotech(ALVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Alvotech(ALVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}